Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease

被引:14
|
作者
Paterson, RLK
Lack, G
Domenico, JM
Delespesse, G
Leung, DYM
Finkel, TH
Gelfand, EW
机构
[1] NATL JEWISH CTR IMMUNOL & RESP MED, DEPT PEDIAT, DIV BASIC SCI, DENVER, CO 80206 USA
[2] NATL JEWISH CTR IMMUNOL & RESP MED, DEPT PEDIAT, DIV ALLERGY IMMUNOL, DENVER, CO 80206 USA
[3] UNIV MONTREAL, NOTRE DAME HOSP, MONTREAL, PQ H3C 3J7, CANADA
关键词
CD40; CD23; atopic disease; B cell;
D O I
10.1002/eji.1830260902
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pathogenesis of atopic disease is closely linked to the overproduction of IgE. CD23 and CD40 are two cellular receptors involved in the regulation of IgE production and both receptors are elevated in atopic disease. We have examined the role of CD40 in the regulation of CD23 and soluble CD23 production in healthy and atopic donors. Triggering of the B cell CD40 receptor directly enhances interleukin (IL)-4-mediated up-regulation of CD23 at both the protein and the mRNA level. When atopic donors were studied, the synergistic effect of CD40 triggering on the IL-4-induced up-regulation of CD23 and soluble CD23 (sCD23) was enhanced and there was a relative skewing toward production of sCD23. These studies implicate the CD40 receptor in the hyperproduction of CD23 and sCD23 in atopic disease and suggest that abnormalities may exist in the cellular pathways leading to sCD23 production.
引用
收藏
页码:1979 / 1984
页数:6
相关论文
共 50 条
  • [1] The roles of CD40 and CD23 in IgE regulation
    Yasui, T
    Fujiwara, H
    Kamanaka, M
    Kawabe, T
    Yoshida, N
    Kishimoto, T
    Kikutani, H
    [J]. NEW HORIZONS IN ALLERGY IMMUNOTHERAPY, 1996, 409 : 349 - 354
  • [2] CELL CELL-INTERACTIONS FOR CD23 EXPRESSION AND SOLUBLE CD23 RELEASE FROM PERIPHERAL LYMPHOCYTES OF ATOPIC DONORS
    KICZA, K
    FISCHER, A
    PFEIL, T
    BUJANOWSKIWEBER, J
    KONIG, W
    [J]. IMMUNOLOGY, 1989, 68 (04) : 532 - 539
  • [3] CD40 triggering and IFN gamma synergized with soluble CD23 (sCD23) to trigger TNF alpha release by human monocytes.
    Hermann, P
    Armitage, R
    Sarfati, M
    [J]. FASEB JOURNAL, 1996, 10 (06): : 1948 - 1948
  • [4] Expression of CD23/CD21 and CD40/CD40 ligand in vernal keratoconjunctivitis
    Abu El-Asrar, AM
    Fatani, RA
    Missotten, L
    Geboes, K
    [J]. EYE, 2001, 15 (2) : 217 - 224
  • [5] Expression of CD23/ CD21 and CD40/CD40 ligand in vernal keratoconjunctivitis
    Ahmed M Abu El-Asrar
    Rashed A Fatani
    Luc Missotten
    Karel Geboes
    [J]. Eye, 2001, 15 : 217 - 224
  • [6] INTERLEUKIN-4 AND SOLUBLE CD23 SERUM LEVELS IN ASTHMATIC ATOPIC CHILDREN
    DAHER, S
    SANTOS, LMB
    SOLE, D
    DELIMA, MG
    NASPITZ, CK
    MUSATTI, CC
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY, 1995, 5 (05): : 251 - 254
  • [7] ROLE OF CD23 AND SCD23 IN ATOPIC DISEASE
    BUJANOWSKIWEBER, J
    WAHN, U
    BERGMANN, KE
    KONIG, W
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (01) : 207 - 207
  • [8] Soluble CD23 is increased in allergy
    Boccafogli, A
    Vicentini, L
    Lambertini, D
    Scolozzi, R
    [J]. ALLERGY, 1997, 52 (03) : 357 - 358
  • [9] Soluble forms of CD23, CD8, and CD25 in atopic patients
    PeteiroCartelle, FJ
    BalAlvaredo, MJ
    FernandezSantamaria, MA
    DominguezHernandez, V
    RosalesRodriguez, M
    [J]. JOURNAL OF CLINICAL LIGAND ASSAY, 1995, 18 (04): : 252 - 254
  • [10] Plasma soluble CD23 and interleukin-4 concentrations in atopic children with bronchial asthma
    Kutukculer, E
    Demir, E.
    Tanac, R.
    Caglayan, S.
    [J]. Turkish Journal of Medical Sciences, 1997, 27 (04):